St. Vincent’s hospital became the first in the state to successfully implant a new technology that helps circulate blood flow ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Rapamycin is typically prescribed to organ transplant patients to suppress their immune systems. But many scientists and ...

Belzutifan improved progression-free survival and objective response rate compared to everolimus in previously treated ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has ...

Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell ...

Afinitor (everolimus) is a prescription drug that’s used to treat some types of cancer, seizures, and certain tumors. This drug can interact with other medications and some supplements.

Continued use of systemic glucocorticoids, a calcineurin inhibitor (tacrolimus or cyclosporine), or a mammalian target of rapamycin (mTOR) inhibitor (sirolimus or everolimus) that the patient was ...

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the ...

Researchers have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated. Their findings suggest a potential ...